Eribuline Ever Pharma

Eribulin is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin is primarily used in the treatment of metastatic breast cancer. It is administered intravenously and is designed to target and destroy cancer cells. The drug is often considered when other treatments have not been effective. Eribulin may also be used in other types of cancer, but this is determined by a healthcare provider based on individual patient needs.

Common effects of Eribulin may include fatigue, nausea, and hair loss. Some patients may experience a decrease in white blood cells, which can increase the risk of infections. It is important to monitor for any unusual symptoms and report them to a healthcare provider.

Eribulin should be handled with care, as it is a potent chemotherapy agent. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Pregnant women or those planning to become pregnant should discuss the potential risks with their doctor.

Eribulin may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eribulin.